Buprenorphine X-waiver exemption – beyond the basics for the obstetrical provider
Volume: 3, Issue: 6, Pages: 100451 - 100451
Published: Nov 1, 2021
Abstract
Buprenorphine is 1 of 3 medications approved by the US Food and Drug Administration for the treatment of opioid use disorder, and practitioners must obtain a federal waiver to prescribe buprenorphine. Until recently, physicians and advanced practice clinicians were required to complete 8 and 24 hours of training, respectively, before applying for this waiver and to provide psychosocial services when prescribing buprenorphine to ≤30 patients. The...
Paper Details
Title
Buprenorphine X-waiver exemption – beyond the basics for the obstetrical provider
Published Date
Nov 1, 2021
Volume
3
Issue
6
Pages
100451 - 100451
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History